About Egetis

Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment

History

PledPharma AB was founded in 2006 and is listed on Nasdaq Stockholm’s main market, since October 31, 2019.

On November 3, 2020, the company acquired Rare Thyroid Therapeutics AB (RTT). Together with RTT, the new company Egetis Therapeutics AB was formed.

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com